Table 2. ICU admission and organic dysfunction.
| Global | AKI | No AKI | p | |
|---|---|---|---|---|
| (n = 1642) | (n = 618, 40.1%) | (n = 923, 59.9%) | ||
| Diagnosis at admission | ||||
| Viral pneumonia n (%) | 1553 (94.6) | 600 (97.1) | 899 (97.4) | 0.712 |
| COPD exacerbation n (%) | 16 (1) | 8 (1.3) | 8 (0.9) | 0.417 |
| Acute asthma n (%) | 17 (1) | 5 (0.8) | 12 (1.3) | 0.366 |
| Heart failure n (%) | 23 (1.4) | 14 (2.3) | 9 (1) | 0.041 |
| Other n (%) | 47 (2.9) | 134 (21.7) | 103 (11.2) | 0.362 |
| Severity of the ARDS | <0.001 | |||
| Mild n (%) | 127 (7.9) | 28 (4.6) | 92 (10.1) | |
| Moderate n (%) | 514 (32.7) | 168 (27.5) | 330 (36.3) | |
| Severe n (%) | 935 (59.4) | 416 (68) | 488 (53.6) | |
| Organic dysfunction at admission | ||||
| Shock n (%) | 447 (27.2) | 276 (44.7) | 155 (16.8) | <0.001 |
| AKI n (%) | 467 (28.4) | |||
| Hepatic failure n (%) | 291 (17.7) | 158 (25.6) | 131 (14.2) | <0.001 |
| Coagulopathy n (%) | 245 (14.9) | 134 (21.7) | 103 (11.2) | <0.001 |
| Neurological alteration n (%) | 189 (11.5) | 102 (16.5) | 83 (9) | <0.001 |
| Thrombocytopenia n (%) | 169 (19.3) | 100 (16.2) | 68 (7.4) | <0.001 |
COPD- Chronic obstructive pulmonary disease
ARDS- Acute respiratory distress syndrome
AKI- Acute kidney injury.